Rob Schacter to Participate in Panel Session at BIO 2006 Annual Convention

SAN FRANCISCO, California, April 10, 2006 (BUSINESS WIRE) – Robert Schacter, president and founder of Reedland Capital Partners, an Institutional Division of Financial West Group, will participate in a panel discussion at the BIO 2006 Annual International Convention entitled “Short-Selling: How Can the Biotech Company Cope?,” being held in the Finance Track, on Wednesday, April 12, 2006 from 9:15AM – 10:45AM in room 426C at the McCormick Convention Center in Chicago.

BIO 2006, the Biotechnology Industry Organization’s annual convention, is taking place April 9-12, 2006 in Chicago at McCormick Place. The convention is expected to draw 18,000 CEOs, researchers, policymakers, journalists, and venture capitalists for three days of networking and learning. BIO 2006 will feature more than 180 educational sessions and workshops on finance, partnering, R&D, science and policy.

BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and 31 other nations. BIO members are involved in the research and development of health-care, agricultural, industrial and environmental biotechnology products.

About Reedland Capital Partners

Reedland Capital Partners is a San Francisco-based boutique investment banking firm which specializes in structuring and arranging institutional equity and debt financings for publicly-held companies and select privately-held companies. Since 1998, Reedland has successfully arranged over $1.8 billion in financings for companies located all over the United States and Canada in over a dozen different industries, with extensive experience structuring PIPE transactions for biotech and healthcare companies. For more information regarding Reedland, please see

For further information, please contact Jason E. Cohen, Reedland Capital Partners 415-383-4700.